In a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine ...

Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the ...

Researchers have discovered in an ongoing phase IIb trial that a single intravitreal injection of UBX1325 (foselutoclax), a ...

In this Healio Video Perspective from the ARVO meeting, Justis P. Ehlers, MD, shares results from the phase 1 HELIOS study ...

IDE Group recently unveiled OKO, its new ophthalmic auto-injector for improving drug delivery precision and efficiency.

The company announced 27 abstracts at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting ...

Researchers found that higher urinary levels of caffeine and specific metabolites, especially in men, were significantly ...

In 2023, the FDA approved aflibercept 8 mg for wet AMD, DME, and diabetic retinopathy ... to return within 4 days of treatment after injection, Charbel Issa and team said. "Mild, self-limiting ...

Scientists say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier, an important boundary that regulates the flow of nutrients, waste and ...